Role of NKT cells in the acceptance of islet xenograftsin mice treated with anti-CD4 monoclonal antibody
NKT细胞在接受抗CD4单克隆抗体处理的小鼠胰岛异种移植物中的作用
基本信息
- 批准号:10671145
- 负责人:
- 金额:$ 2.43万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Pancreatic islet transplantation represents a potential treatment for insulin-dependent diabetes mellitus. However. the precise cellular and molecular mechanisms of the immune reactions against allogeneic and xenogeneic transplanted islets remain nuclear. In the present study, we demonstrate that CD4a+ Vα l4 NKT cells, a distinct lymphoid cell lineage recently identified, are required for the acceptance of intrahepatic rat islet xenografts. Rat islet xenografts were accepted by C57BL/6 mice when certain doses of anti-CD4mAb were administrated after transplantation. No immunosuppressive drug is required in this procedure. The dose or anti-CD4mAb was critical, and the beneficial effect appeared to be associated with reappearance of CD4 + NKT cells around 14 days after transplantation. The anti-CD4mAb-mediated acceptance of rat islet xenografts was not observed in Vα 14 NKT cell-deficient mice, where essentially no Vα 14 NKT cells exist and conventional lymphoid cells remain intact. Moreover, the adoptive transfer of Vα 14 NKT cells into Vα 14 NKT cell-deficient mice reconstituted acceptance of rat islet xenografts. These results indicate that Vα 14 NKT cells play a crucial role in the acceptance of rat islet xenografts in mice treated with anti-CD4 antibody.
胰岛移植是治疗胰岛素依赖型糖尿病的一种潜在方法。然而。针对异体和异种移植胰岛的免疫反应的确切的细胞和分子机制仍然是核的。在本研究中,我们证明了CD4a+VαL4NKT细胞是接受大鼠肝内胰岛移植所必需的,这是最近发现的一种独特的淋巴样细胞谱系。C57BL/6小鼠在移植后给予一定剂量的抗CD4单抗后,可接受大鼠胰岛移植。在这个过程中不需要免疫抑制药物。抗CD4mAb的剂量是关键的,其有益效果似乎与移植后14天左右CD4+NKT细胞的再次出现有关。在Vα14NKT细胞缺陷小鼠中未观察到抗CD4mAb介导的大鼠胰岛异种移植的接受性,Vα14NKT细胞基本上不存在,而常规淋巴样细胞保持完好。此外,将Vα14NKT细胞过继转移到Vα14NKT细胞缺陷小鼠体内,重建了对大鼠胰岛异种移植的接受性。这些结果表明,VCD414NKT细胞在抗α抗体处理的小鼠接受大鼠胰岛异种移植中起着关键作用。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M. Nakano: "Hepatocyte growth factor is essential for amelioration of hyperghreuie in STZ-induced dia betic mice receiving a margi nel mass of・……"TRANSPLANTATION. 69. 214-221 (2000)
M. Nakano:“肝细胞生长因子对于改善 STZ 诱导的糖尿病小鼠的高血糖至关重要,该小鼠接受了边缘质量......”移植。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Ikehara,Y.Yasunami et al: "CD4+D214NKT cells are essential for the acceptance of intra hepatic islet xenografts is mice"J Clin Invest,accepted for publicalis.
Y.Ikehara、Y.Yasunami 等人:“CD4 D214NKT 细胞对于小鼠肝内胰岛异种移植物的接受至关重要”,J Clin Invest,已接受 publicalis。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Yasunai,et al: "Cellular immune response in the liver of mice rejectiry dutra bepati rat and quniea p.g sid xenoprabts:expansins of intervedatte TCR cell" Transplantatm Proceedings. 32・2. 581 (1998)
Y. Yasunai 等人:“排斥 dutra bepati 大鼠和 Quniea p.g sid xenoprabts 的肝脏中的细胞免疫反应:介入 TCR 细胞的扩展”Transplantatm Proceedings 32・2。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Nakano,Y.Yasunami,et al: "Hepatocyte growth factor is essential for amelioration of hyperglycemia in STZ-induced diabetic mice receiving a marginal."TRANSPCANTATION. 69・2. 214-221 (2000)
M. Nakano、Y. Yasunami 等人:“肝细胞生长因子对于接受边缘移植的 STZ 诱导的糖尿病小鼠的高血糖至关重要。”214-221。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.nagai,Y.Yasunami,et al: "Acceptance of intrabepatic isld alloprobis without immunosupruni in the limited strain asubination of muce from C57BL/6 to BACK" Transplantetium Proceedings. 30・2. 418 (1998)
T.nagai、Y.Yasunami 等人:“从 C57BL/6 到 BACK 的小鼠有限菌株 asubination 中接受肝内 isld alloprobis”(1998 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YASUNAMI Yohichi其他文献
YASUNAMI Yohichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YASUNAMI Yohichi', 18)}}的其他基金
Formation of insulin-producing cells from iPS cells in conjunction with islet transplantation
结合胰岛移植从 iPS 细胞形成胰岛素产生细胞
- 批准号:
23659627 - 财政年份:2011
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Prevention of early loss of transplanted islets by targeting Na+/Ca2+exchanger of donor islets prior to transplantation
移植前通过靶向供体胰岛的 Na /Ca2 交换剂来预防移植胰岛的早期损失
- 批准号:
22390251 - 财政年份:2010
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel procedure targeting NKT cells facilitating successful clinical islet transplantation
开发针对 NKT 细胞的新程序,促进临床胰岛移植的成功
- 批准号:
18390354 - 财政年份:2006
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Dissection on islet graft loss in association with engraftments in the liver
与肝脏植入相关的胰岛移植损失的解剖
- 批准号:
15390386 - 财政年份:2003
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of NKT cells in acceptance of pancreatic islet allografts in mice.
NKT 细胞在小鼠胰岛同种异体移植物接受中的作用。
- 批准号:
12671189 - 财政年份:2000
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
The role of cMaf on the development of IL-17-producing invariant NKT cells.
cMaf 对产生 IL-17 的恒定 NKT 细胞发育的作用。
- 批准号:
21K07066 - 财政年份:2021
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of immunotherapy using iPS-NKT cells for glioblastoma
使用 iPS-NKT 细胞治疗胶质母细胞瘤的免疫疗法的开发
- 批准号:
20K17917 - 财政年份:2020
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identification of molecules recognized by invariant NKT cells independently of CD1d
独立于 CD1d 的恒定 NKT 细胞识别分子的鉴定
- 批准号:
20K17408 - 财政年份:2020
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Purinergic Modulation of NKT Cells Ameliorates Hyperoxic Lung Injury
NKT 细胞的嘌呤能调节可改善高氧性肺损伤
- 批准号:
10162646 - 财政年份:2019
- 资助金额:
$ 2.43万 - 项目类别:
NKT cells control obesity by regulating the microbiota
NKT 细胞通过调节微生物群来控制肥胖
- 批准号:
19K09011 - 财政年份:2019
- 资助金额:
$ 2.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Purinergic Modulation of NKT Cells Ameliorates Hyperoxic Lung Injury
NKT 细胞的嘌呤能调节可改善高氧性肺损伤
- 批准号:
10396623 - 财政年份:2019
- 资助金额:
$ 2.43万 - 项目类别:
Genetically Modified NKT Cells to Target Viral Reservoirs
转基因 NKT 细胞靶向病毒库
- 批准号:
9908047 - 财政年份:2019
- 资助金额:
$ 2.43万 - 项目类别:














{{item.name}}会员




